Cargando…

Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation

The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Purves-Tyson, Tertia D., Weber-Stadlbauer, Ulrike, Richetto, Juliet, Rothmond, Debora A, Labouesse, Marie A., Polesel, Marcello, Robinson, Kate, Shannon Weickert, Cynthia, Meyer, Urs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910216/
https://www.ncbi.nlm.nih.gov/pubmed/31168068
http://dx.doi.org/10.1038/s41380-019-0434-0
_version_ 1783656083230818304
author Purves-Tyson, Tertia D.
Weber-Stadlbauer, Ulrike
Richetto, Juliet
Rothmond, Debora A
Labouesse, Marie A.
Polesel, Marcello
Robinson, Kate
Shannon Weickert, Cynthia
Meyer, Urs
author_facet Purves-Tyson, Tertia D.
Weber-Stadlbauer, Ulrike
Richetto, Juliet
Rothmond, Debora A
Labouesse, Marie A.
Polesel, Marcello
Robinson, Kate
Shannon Weickert, Cynthia
Meyer, Urs
author_sort Purves-Tyson, Tertia D.
collection PubMed
description The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contributing to presynaptic dopamine abnormalities. Thus, we quantified inflammatory markers in dopaminergic areas of the midbrain of people with schizophrenia and matched controls. We also measured these markers in midbrain of mice exposed to maternal immune activation (MIA) during pregnancy, an established risk factor for schizophrenia and other psychiatric disorders. We found diagnostic increases in SERPINA3, TNFα, IL1β, IL6, and IL6ST transcripts in schizophrenia compared with controls (p < 0.02–0.001). The diagnostic differences in these immune markers were accounted for by a subgroup of schizophrenia cases (~ 45%, 13/28) showing high immune status. Consistent with the human cohort, we identified increased expression of immune markers in the midbrain of adult MIA offspring (SERPINA3, TNFα, and IL1β mRNAs, all p ≤ 0.01), which was driven by a subset of MIA offspring (~ 40%, 13/32) with high immune status. There were no diagnostic (human cohort) or group-wise (mouse cohort) differences in cellular markers indexing the density and/or morphology of microglia or astrocytes, but an increase in the transcription of microglial and astrocytic markers in schizophrenia cases and MIA offspring with high inflammation. These data demonstrate that immune-related changes in schizophrenia extend to dopaminergic areas of the midbrain and exist in the absence of changes in microglial cell number, but with putative evidence of microglial and astrocytic activation in the high immune subgroup. MIA may be one of the contributing factors underlying persistent neuroimmune changes in the midbrain of people with schizophrenia.
format Online
Article
Text
id pubmed-7910216
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79102162021-03-15 Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation Purves-Tyson, Tertia D. Weber-Stadlbauer, Ulrike Richetto, Juliet Rothmond, Debora A Labouesse, Marie A. Polesel, Marcello Robinson, Kate Shannon Weickert, Cynthia Meyer, Urs Mol Psychiatry Article The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contributing to presynaptic dopamine abnormalities. Thus, we quantified inflammatory markers in dopaminergic areas of the midbrain of people with schizophrenia and matched controls. We also measured these markers in midbrain of mice exposed to maternal immune activation (MIA) during pregnancy, an established risk factor for schizophrenia and other psychiatric disorders. We found diagnostic increases in SERPINA3, TNFα, IL1β, IL6, and IL6ST transcripts in schizophrenia compared with controls (p < 0.02–0.001). The diagnostic differences in these immune markers were accounted for by a subgroup of schizophrenia cases (~ 45%, 13/28) showing high immune status. Consistent with the human cohort, we identified increased expression of immune markers in the midbrain of adult MIA offspring (SERPINA3, TNFα, and IL1β mRNAs, all p ≤ 0.01), which was driven by a subset of MIA offspring (~ 40%, 13/32) with high immune status. There were no diagnostic (human cohort) or group-wise (mouse cohort) differences in cellular markers indexing the density and/or morphology of microglia or astrocytes, but an increase in the transcription of microglial and astrocytic markers in schizophrenia cases and MIA offspring with high inflammation. These data demonstrate that immune-related changes in schizophrenia extend to dopaminergic areas of the midbrain and exist in the absence of changes in microglial cell number, but with putative evidence of microglial and astrocytic activation in the high immune subgroup. MIA may be one of the contributing factors underlying persistent neuroimmune changes in the midbrain of people with schizophrenia. Nature Publishing Group UK 2019-06-05 2021 /pmc/articles/PMC7910216/ /pubmed/31168068 http://dx.doi.org/10.1038/s41380-019-0434-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Purves-Tyson, Tertia D.
Weber-Stadlbauer, Ulrike
Richetto, Juliet
Rothmond, Debora A
Labouesse, Marie A.
Polesel, Marcello
Robinson, Kate
Shannon Weickert, Cynthia
Meyer, Urs
Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
title Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
title_full Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
title_fullStr Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
title_full_unstemmed Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
title_short Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
title_sort increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910216/
https://www.ncbi.nlm.nih.gov/pubmed/31168068
http://dx.doi.org/10.1038/s41380-019-0434-0
work_keys_str_mv AT purvestysontertiad increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT weberstadlbauerulrike increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT richettojuliet increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT rothmonddeboraa increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT labouessemariea increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT poleselmarcello increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT robinsonkate increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT shannonweickertcynthia increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation
AT meyerurs increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation